F D Lee

Author PubWeight™ 114.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci U S A 1973 9.09
2 An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc Natl Acad Sci U S A 1973 8.45
3 Intestinal spirochaetosis. Gut 1971 7.31
4 Is duodenitis a dyspeptic myth? Lancet 1977 6.17
5 Intestinal spirochaetosis. Br Med J 1967 4.98
6 Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992 4.27
7 Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol 1989 4.07
8 A cloned MCGF cDNA encodes a multilineage hematopoietic growth factor: multiple activities of interleukin 3. J Immunol 1985 2.56
9 Interaction of the trp repressor and RNA polymerase with the trp operon. J Mol Biol 1975 2.23
10 Mechanism for transforming growth factor beta and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures. J Immunol 1990 1.71
11 Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science 1986 1.60
12 Sigmoidoscopic and microscopic appearance of the rectal mucosa in homosexual men. Gut 1981 1.59
13 An anatomical study of the nerve supply of the breast, including the nipple and areola. Br J Plast Surg 1996 1.54
14 Duodenitis. Clin Gastroenterol 1978 1.53
15 Hypothesis: symmetrical cutaneous lymphoma. Lancet 1990 1.45
16 Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis. Q J Med 1986 1.44
17 Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders. J Clin Pathol 1990 1.36
18 Serological diagnosis of Helicobacter pylori--evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs. Gut 1993 1.32
19 Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type beta-induced isotype switching. Proc Natl Acad Sci U S A 1990 1.31
20 Collagenous colitis: possible response to sulfasalazine and local steroid therapy. Gastroenterology 1985 1.30
21 A comparative study of Kaposi's sarcoma and granuloma pyogenicum in Uganda. J Clin Pathol 1968 1.21
22 Jejunal morphology of the African in Uganda. J Pathol 1969 1.20
23 Acute pancreatitis after cimetidine administration in experimental duodenal ulcers. Lancet 1978 1.15
24 Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration. J Clin Pathol 1992 1.14
25 Immunological abnormalities in splenic atrophy. Lancet 1975 1.12
26 Crohn's disease of the mouth: an indicator of intestinal involvement. Gut 1982 1.08
27 Observer variability in histopathological reporting of malignant bronchial biopsy specimens. J Clin Pathol 1994 1.07
28 Immunocytochemical demonstration of p21 ras family oncogene product in normal mucosa and in premalignant and malignant tumours of the colorectum. Br J Cancer 1985 0.99
29 Radiation enteritis with malabsorption. Gut 1965 0.99
30 Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal anti-inflammatory drugs. Gut 1993 0.98
31 The jejunum after kwashiorkor. Lancet 1966 0.98
32 A sensitive method of screening for dominant T cell clones by amplification of T cell gamma gene rearrangements with the polymerase chain reaction. J Pathol 1990 0.94
33 Abrogation of IL-3 dependent growth requires a functional v-src gene product: evidence for an autocrine growth cycle. Oncogene 1990 0.94
34 Evaluation of endoscopic brush and biopsy touch smear cytology and biopsy histology in the diagnosis of carcinoma of the lower oesophagus and cardia. J Clin Pathol 1980 0.94
35 Nature of the mucosal changes associated with malignant neoplasms in the small intestine. Gut 1966 0.92
36 Predicting NSAID related ulcers--assessment of clinical and pathological risk factors and importance of differences in NSAID. Gut 1994 0.91
37 Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease. J Clin Pathol 1986 0.91
38 Diagnostic tests for Helicobacter pylori: comparison and influence of non-steroidal anti-inflammatory drugs. J Clin Pathol 1992 0.91
39 Small-intestinal changes induced by an elemental diet (Vivonex) in normal rats. Clin Sci Mol Med 1978 0.91
40 Histology of rectal gonorrhoea in men, with a note on anorectal infection with Neisseria meningitidis. J Clin Pathol 1983 0.91
41 Risk of dysplasia in the columnar cuff after stapled restorative proctocolectomy. Br J Surg 2003 0.90
42 The distribution of the c-myc oncogene product in malignant lymphomas and various normal tissues as demonstrated by immunocytochemistry. Br J Cancer 1986 0.90
43 Diabetes mellitus and primary hepatocellular carcinoma. Q J Med 1986 0.90
44 Consistency of histopathological reporting of laryngeal dysplasia. The Scottish Pathology Consistency Group. Histopathology 2000 0.90
45 Observer variability in histopathological reporting of non-small cell lung carcinoma on bronchial biopsy specimens. J Clin Pathol 1996 0.90
46 Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers. Gastroenterology 1999 0.89
47 The interaction between Helicobacter pylori culture filtrate and indomethacin: effects on the integrity of human gastric antral mucosa and its prostaglandin E2 production in vitro. Aliment Pharmacol Ther 1990 0.89
48 Endoscopic cytology and biopsy in the upper gastrointestinal tract. Clin Gastroenterol 1978 0.89
49 Pseudomembranous colitis as infectious disease. Lancet 1981 0.87
50 Observer variability in the histopathological reporting of abnormal rectal biopsy specimens. J Clin Pathol 1994 0.87
51 Coeliac disease associated with recurrent aphthae. Gut 1980 0.86
52 Effect of omeprazole therapy on the survival of Helicobacter pylori, urease activity, and antral gastric histology in patients with duodenal ulcer. Helicobacter 1996 0.85
53 Gastric antral vascular ectasia (watermelon stomach)--therapeutic options. Postgrad Med J 1990 0.84
54 Acute mesenteric ischaemia: a presenting feature of coeliac disease? Br Med J (Clin Res Ed) 1987 0.84
55 Morphological and immunohistochemical characteristics of T-cell malignant lymphomas in the west of Scotland. Histopathology 1986 0.83
56 Oesophageal histology in long term users of non-steroidal anti-inflammatory drugs. J Clin Pathol 1994 0.82
57 Malignant histiocytosis complicating rheumatoid arthritis: report of four cases. J Clin Pathol 1986 0.82
58 Long-term cancer risk of the anorectal cuff following restorative proctocolectomy assessed by p53 expression and cuff dysplasia. Colorectal Dis 2007 0.82
59 Inhibition of human gastric cyclic AMP production by Helicobacter pylori protein--possible involvement of mucosal prostaglandin E2. Aliment Pharmacol Ther 1991 0.81
60 Myelofibrosis complicated by intestinal extramedullary haemopoiesis and acute small bowel obstruction. J Clin Pathol 1986 0.81
61 Comment on a recent paper and editorial on the subject of dysplasia classification. J Pathol 2002 0.81
62 Genomic rearrangements of the c-myc proto-oncogene in human malignant lymphomas. J Pathol 1986 0.80
63 T-cell lymphoblastic lymphoma of the uterus complicated by Chlamydia trachomatis pneumonia. Postgrad Med J 1986 0.80
64 The endoscopic and histological features of peptic duodenitis. Scand J Gastroenterol Suppl 1979 0.79
65 Cyclosporine A induced colitis and acquired selective IgA deficiency in a patient with juvenile chronic arthritis. J Rheumatol 1993 0.79
66 A retrospective assessment of the clinical value of jejunal disaccharidase analysis. Scand J Gastroenterol 1994 0.78
67 The relation of ras family oncogene expression to conventional staging criteria and clinical outcome in colorectal carcinoma. Br J Cancer 1986 0.78
68 Elemental diet composition and the structure and function of rat small intestine: comparison of the effects of two diets on morphology and in vivo absorption of water. JPEN J Parenter Enteral Nutr 1981 0.77
69 Observer variability in the histopathological reporting of needle biopsy specimens of the prostate. Hum Pathol 1997 0.76
70 Spiral shaped microorganisms in the human duodenal mucosa. Postgrad Med J 1991 0.76
71 Evaluation of 3-fucosyl N-acetyllactosamine antibody staining in histological assessment of CIN. J Clin Pathol 1990 0.75
72 Coeliac disease and lymphoma. Lancet 1991 0.75
73 Clostridium difficile isolated from the stool of a patient with pseudomembranous colits following ampicillin plus flucloxacillin (Magnapen) therapy. Postgrad Med J 1980 0.75
74 Papular mucinosis: is the inflammatory cell infiltrate neoplastic? The presence of a monotypic plasma cell population demonstrated by in situ hybridization. Br J Dermatol 1996 0.75
75 Current views on cervical neoplasia. J Clin Pathol 1992 0.75
76 Comparison of in situ hybridisation and polymerase chain reaction in the diagnosis of B cell lymphoma. J Clin Pathol 1998 0.75
77 Ulceration of the entire small intestine accompanied by rash, hepatitis and pancytopenia. Postgrad Med J 1989 0.75
78 Is rheumatoid arthritis really a consequence of benign T cell neoplasia? J Pathol 1990 0.75
79 Submucosal lipophages in diverticula of the small intestine. J Pathol Bacteriol 1966 0.75
80 Effect of an elemental diet (Vivonex) on the absorption abnormalities and histological appearances of the jejunum in untreated adult coeliac disease. Digestion 1979 0.75
81 Radiation-driven hydrodynamics of high- hohlraums on the national ignition facility. Phys Rev Lett 2005 0.75
82 Observer variability in the Goseki grouping of gastric adenocarcinoma in resection and biopsy specimens. Histopathology 2003 0.75
83 Immunological studies in splenic atrophy. Br J Haematol 1971 0.75
84 The effect of cimetidine and 15(S) 15-methyl prostaglandin E2 on the healing of laser-induced gastric mucosal damage. Gastrointest Endosc 1982 0.75
85 Tests of small-intestinal function--digestion, absorption, secretion. Clin Gastroenterol 1978 0.75
86 Does occult monoclonal proliferation of non-malignant T cells cause secondary immunopathological disorders? J Pathol 1989 0.75
87 Safety in clinical laboratories. Lancet 1979 0.75